Genmab to buy Dutch cancer drugmaker Merus for $8 billion
Genmab(US:GMAB) Reuters·2025-09-29 05:19Denmark's Genmab has agreed to acquire Merus NV , a Nasdaq-listed Dutch biotech firm developing a head-and-neck cancer drug, for $8 billion in cash, the two companies said on Monday. ...